Episode 22 COVID-19 Updates: Conversation with Dr. Gigi Gronvall 

Thursday, September 3, 2020

Dialogue 08:00 EST/20:00 HKT, Close 09:00 EST/21:00 HKT

On January 30, the World Health Organization declared a global health emergency on the spread of the novel coronavirus (COVID-19) that originated in Wuhan. Healthcare experts have warned that COVID-19 could rapidly spread, if not properly contained, and many governments around the world have begun to take precautionary measures to ensure public health safety. Amid the international concern and heightened fears about the disease, what is fact and what is fiction? Asia Society Hong Kong Center brings you regular updates on COVID-19 that has global reverberations, and presents on-the-ground public health experts and internationally renowned specialists with the latest facts and evidence-based findings. In episode 22, hear from Dr. Gigi Gronvall, Senior Scholar at the Johns Hopkins Center for Health Security, and Associate Professor in the Department of Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health. S. Alice Mong, Executive Director of Asia Society Hong Kong Center, will moderate the discussion.

Gigi Gronvall is Senior Scholar at the Johns Hopkins Center for Health Security, and Associate Professor in the Department of Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health. She is an immunologist by training. During the COVID-19 pandemic, Dr. Gronvall has led the Center’s ongoing efforts to track the development and marketing of molecular and antigen tests and serology tests as well as the development of national strategies for COVID-19 serology tests and SARS-CoV-2 serosurveys in the United States. She is a member of the Novel and Exceptional Technology and Research Advisory Committee (NExTRAC), which provides recommendations to the U.S. National Institutes of Health Director, and is a public forum for the discussion of the scientific, safety and ethical issues associated with emerging biotechnologies. Dr. Gronvall received a Bachelor of Science in Biology from Indiana University, Bloomington, and received a Ph.D. from Johns Hopkins University for her work on T-cell receptor/MHC I interactions.

Got questions?

Go to www.slido.com and enter code #1567